Here we briefly review our understanding of the immune response to myelin-derived glycolipids during an inflammatory autoimmune response in the central nervous system (CNS). We focus primarily on the recognition of the self-glycolipid sulfatide by a distinct population of non-invariant NK T cells. The results of studies we have obtained so far in investigating the presentation of sulfatide by CNS-resident cells including microglia and their interactions with T cells indicate that this pathway might be successfully targeted for the treatment of autoimmune demyelination in multiple sclerosis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11064-006-9145-4 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!